These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8416183)

  • 1. Ischaemic heart disease, lipids and the kidney.
    Brown JH; Short CD; Mallick NP
    Contrib Nephrol; 1993; 102():198-219. PubMed ID: 8416183
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid abnormalities in renal disease.
    Majumdar A; Wheeler DC
    J R Soc Med; 2000 Apr; 93(4):178-82. PubMed ID: 10844882
    [No Abstract]   [Full Text] [Related]  

  • 3. Disorders of blood-lipids in renal disease.
    Cramp DG; Moorhead JF; Wills MR
    Lancet; 1975 Mar; 1(7908):672-3. PubMed ID: 47091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid abnormalities in progressive renal insufficiency.
    Attman PO; Samuelsson O; Alaupovic P
    Contrib Nephrol; 1997; 120():1-10. PubMed ID: 9257042
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic heart disease after renal transplantation.
    Kasiske BL
    Kidney Int; 2002 Jan; 61(1):356-69. PubMed ID: 11786124
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperlipidaemia and renal disease.
    Short CD; Durrington PN
    Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):777-806. PubMed ID: 2082906
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A; Maíz A; Arteaga A
    Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormalities of lipid metabolism in chronic dialysis patients].
    Fujioka T; Saito E; Yasugi T; Shimizu T
    Nihon Rinsho; 1992 Jan; 50 Suppl():527-34. PubMed ID: 1578734
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperlipidemia in patients with chronic renal disease.
    Kasiske BL
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S142-56. PubMed ID: 9820472
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent trends in the therapy of hyperlipidemia in nephrotic syndrome].
    Campanacci L; Guarnieri GF; Faccini L; Bellini G; Gambari PF
    G Clin Med; 1973 Oct; 54(10):714-33. PubMed ID: 4789301
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipoprotein metabolism in the nephrotic syndrome.
    Warwick GL; Packard CJ
    Nephrol Dial Transplant; 1993; 8(5):385-96. PubMed ID: 8393541
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome.
    Kaysen GA; Don B; Schambelan M
    Nephrol Dial Transplant; 1991; 6(2):141-9. PubMed ID: 1857529
    [No Abstract]   [Full Text] [Related]  

  • 15. Dialysis modalities and dyslipidemia.
    Attman PO; Samuelsson O; Johansson AC; Moberly JB; Alaupovic P
    Kidney Int Suppl; 2003 May; (84):S110-2. PubMed ID: 12694322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders of carbohydrate and lipid metabolism in uremia.
    Bagdade
    Nephron; 1975; 14(2):153-62. PubMed ID: 1093054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and treatment of dyslipidemia of renal diseases.
    Toto RD; Vega GL; Grundy SM
    Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):784-90. PubMed ID: 7922219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in serum lipoproteins in kidney diseases. Therapeutic possibilities].
    Walther A; Mordasini R; Riesen W
    Dtsch Med Wochenschr; 1983 Mar; 108(10):388. PubMed ID: 6337805
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of renal insufficiency in altered erythropoietin metabolism in the nephrotic syndrome.
    Khan IH
    Am J Med; 1992 Sep; 93(3):355-6. PubMed ID: 1524095
    [No Abstract]   [Full Text] [Related]  

  • 20. Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management.
    Saland JM; Ginsberg H; Fisher EA
    Curr Opin Pediatr; 2002 Apr; 14(2):197-204. PubMed ID: 11981290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.